Search Results

Biolinq Incorporated announced the completion of $58 million in financing led by Alpha Wave Ventures, with participation from Niterra’s corporate venture capital fund jointly operated with Pegasus Tech Ventures and existing investors RiverVest Venture Partners, AXA IM Alts, Global Health Investment Corporation, Aphelion Capital, Senvest Management, Features Capital and Taisho Pharmaceutical.

Biolinq Incorporated, a medtech company that is developing novel biosensing technologies, has signed an exclusive license agreement with Taisho Pharmaceutical Co., Ltd., to commercialize a new generation of glucose monitoring products in Japan.

Biolinq Incorporated, a medical device company developing a continuous glucose sensor with a novel integrated display on its wearable device, has announced the closing of a $100 million Series B financing round led by RiverVest Venture Partners.

Biolinq , a medical device company that has developed a novel wearable biosensor platform to measure continuous glucose for the management of diabetes and other clinical conditions, has named Richard Yang as its new Chief Executive Officer. Yang brings to Biolinq more than 20 years of global experience in med-tech innovation, product development and commercial strategy, with expertise in continuous glucose monitoring (CG

Biolinq Inc., the San Diego-based medical device company, announced today that the company has successfully demonstrated the feasibility of a minimally invasive continuous glucose monitor (CGM), showing a high correlation between dermal interstitial glucose and venous blood glucose.

Biolinq announced it has expanded its oversubscribed Series A financing with an additional investment of $4.75 million led by the JDRF T1D Fund, Aphelion Capital and LifeSci Venture Partners.

Biolinq’s first commercial product will allow patients with diabetes to continuously monitor their blood glucose without the pain and hassle of traditional continuous glucose monitoring systems.

Life Science Intelligence (LSI) is hosting the Emerging Medtech Summit February 18-20th, 2020 at The Ritz-Carlton in Laguna Niguel, CA.

MedTech Innovator , the premier nonprofit accelerator in the medical technology industry, today announced the 50 companies selected to participate in the organization’s flagship four-month Showcase and Accelerator program, featuring the industry’s most transformative device, diagnostic, and digital health technologies from around